| 发明名称 |
TREATMENT WITH ANTI-VEGF ANTIBODIES |
| 摘要 |
This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents. |
| 申请公布号 |
US2016304594(A1) |
申请公布日期 |
2016.10.20 |
| 申请号 |
US201615080897 |
申请日期 |
2016.03.25 |
| 申请人 |
Genentech, Inc. |
发明人 |
FYFE Gwendolyn;HOLMGREN Eric;MASS Robert D.;NOVOTNY William |
| 分类号 |
C07K16/22;A61K45/06;A61K31/513;C07K16/30;A61K31/4745;A61K31/555;A61K9/00;A61K39/395;A61K31/519 |
主分类号 |
C07K16/22 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating cancer in a human patient, comprising administering to the patient effective amounts of an anti-VEGF antibody and an anti-neoplastic composition, wherein said anti-neoplastic composition comprises at least one chemotherapeutic agent. |
| 地址 |
South San Francisco CA US |
